June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in...
Contrast Media Injectors
Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in tissues.
-
-
-
November 4, 2019 – The U.S.
-
February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S.
-
There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives. Automated injector systems not only precisely control the amount of contrast used; vendors have moved...
News | Contrast Media | July 22, 2020
July 22, 2020 — The global contrast media market is projected to grow at a CAGR of 4.23% to reach US$7,113.91 million...
News | Contrast Media Injectors | June 29, 2020
June 29, 2020 — Guerbet has launched a new "consumables.guerbet.com" website presenting its Essential and Excellence...
News | Contrast Media Injectors | June 17, 2020
June 17, 2020 — Technavio has been monitoring the contrast injectors market and it is poised to grow by $613.47M during...
Sponsored Content
A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures. Graphic courtesy of Lior Molvin
Blog | Contrast Media | October 15, 2019
When it comes to listing needs, patient safety ranks at the top. Just ask an imaging administrator.
“There is no way we...
Getty Images
News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (...
Sponsored Content | Videos | Contrast Media Injectors | May 22, 2020
At this year’s RSNA ITN sat down with Dennis Durmis, Senior Vice President, Bayer Radiology to discuss Radiology trends...
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.
Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (GBCAs) are widely used in medical imaging to provide essential diagnostic information...
Sponsored Content
Image courtesy of Lior Molvin
Blog | Contrast Media | July 15, 2019
Contrast agents improve every kind of medical image from computed tomography (CT) to magnetic resonance imaging (MR),...
Image courtesy of Guerbet
Feature | Contrast Media Injectors | January 30, 2020 | By Melinda Taschetta-Millane
Contrast media injector technology has seen several recent advances, such as cutting costs by reducing contrast waste...
News | Contrast Media Injectors | December 05, 2019
December 5, 2019 — The newest MEDRAD Stellant FLEX CT Injection System from Bayer takes your contrast delivery to the...
Guerbet presented its Contrast&Care injection management solution at ECR 2018
News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in contrast agents and solutions for medical imaging, today announced...
News | Contrast Media | November 04, 2019
November 4, 2019 – The U.S. Food and Drug Administration (FDA) has approved Clariscan, a macrocyclic, ionic, gadolinium...
Windsong Radiology Group
Sponsored Content | Case Study | Contrast Media Injectors | October 30, 2019
Windsong Radiology Group is a New York-based radiology practice with five locations. Recently, Windsong participated in...
A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures. Graphic courtesy of Lior Molvin
Sponsored Content | Blog | Contrast Media | October 15, 2019
When it comes to listing needs, patient safety ranks at the top. Just ask an imaging administrator.
“There is no way we...
Technology | Contrast Media Injectors | September 11, 2019
September 11, 2019 — Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection...
Image courtesy of Lior Molvin
Sponsored Content | Blog | Contrast Media | July 15, 2019
Contrast agents improve every kind of medical image from computed tomography (CT) to magnetic resonance imaging (MR),...
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.
Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of gadolinium as a contrast agent in...
GU12171120
Sponsored Content | Case Study | Contrast Media Injectors | April 02, 2019
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
News | Interventional Radiology | December 12, 2018
December 12, 2018 — Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media...
Technology | Contrast Media Injectors | December 05, 2018
December 5, 2018 — Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media...
Feature | Contrast Media Injectors | March 07, 2018 | Grand View Research Inc.
The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual...
TriHealth in Cincinnati.
Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
